Push to link medical research innovations to public good.

摘要

Vancouver doctors looking for a more effective way to treat the life-threatening fungal infections of their HIV-positive, injection-drug-addicted patients prompted research into a drug that could also save the lives of patients with parasitic infections in the developing world. And in a deal signed with the University of British Columbia in Vancouver, BC, the promising formulation for an oral dose of amphotericin B - which now has to be administered intravenously - will be developed under the institution's global access principles.